152 related articles for article (PubMed ID: 15984986)
1. Positive predictive value of fecal occult blood testing in persons taking warfarin.
Bini EJ; Rajapaksa RC; Weinshel EH
Am J Gastroenterol; 2005 Jul; 100(7):1586-92. PubMed ID: 15984986
[TBL] [Abstract][Full Text] [Related]
2. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
[TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood test performance indicators in warfarin-treated patients.
Kershenbaum A; Lavi I; Rennert G; Almog R
Dis Colon Rectum; 2010 Feb; 53(2):224-9. PubMed ID: 20087099
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens.
Bini EJ; Kinkhabwala A; Goldfarb DS
Am J Kidney Dis; 2006 Oct; 48(4):580-6. PubMed ID: 16997054
[TBL] [Abstract][Full Text] [Related]
6. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
7. Iron-deficiency anemia due to chronic gastrointestinal bleeding.
Reyes López A; Gómez Camacho F; Gálvez Calderón C; Miño Fugarolas G
Rev Esp Enferm Dig; 1999 May; 91(5):345-58. PubMed ID: 10362876
[TBL] [Abstract][Full Text] [Related]
8. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
10. Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?
Gandhi S; Narula N; Gandhi S; Marshall JK; Farkouh ME
J Gastroenterol Hepatol; 2013 Jun; 28(6):931-6. PubMed ID: 23517228
[TBL] [Abstract][Full Text] [Related]
11. Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening.
Clarke P; Jack F; Carey FA; Steele RJ
Colorectal Dis; 2006 Jun; 8(5):389-92. PubMed ID: 16684082
[TBL] [Abstract][Full Text] [Related]
12. Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission.
Scales CD; Fein S; Muir AJ; Rockey DC
J Clin Gastroenterol; 2006; 40(10):913-8. PubMed ID: 17063111
[TBL] [Abstract][Full Text] [Related]
13. Fecal occult blood testing for colorectal cancer screening: use the finger.
Burke CA; Tadikonda L; Machicao V
Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients.
Hisamuddin K; Mowat NA; Phull PS
Dig Liver Dis; 2006 Jul; 38(7):503-7. PubMed ID: 16522381
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Sakaguchi K; Shiratori Y
Am J Gastroenterol; 2007 Oct; 102(10):2259-64. PubMed ID: 17617203
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional endoscopy in patients with fecal occult blood.
Velez JP; Schwesinger WH; Stauffer J; Gaskill HV; Kazantsev GB; Sirinek KR; Strodel WE
Surg Endosc; 2002 Jan; 16(1):117-20. PubMed ID: 11961620
[TBL] [Abstract][Full Text] [Related]
17. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
[TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy?
Chen YK; Gladden DR; Kestenbaum DJ; Collen MJ
Am J Gastroenterol; 1993 Dec; 88(12):2026-9. PubMed ID: 8249968
[TBL] [Abstract][Full Text] [Related]
20. An audit of the utility of in-patient fecal occult blood testing.
Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW
Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
